Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ORGO | Class A Common Stock | Award | $0 | +187K | +39.69% | $0.00 | 659K | Feb 21, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ORGO | Stock Option (Right to Buy) | Award | $0 | +339K | $0.00 | 339K | Feb 21, 2024 | Class A Common Stock | 339K | $3.43 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2024. |
F2 | The option becomes exercisable in equal annual installments over four years beginning February 15, 2024. |